Benitec Biopharma Inc. (BNTC) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM). Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Price / Book | 2.53 |
| FCF Yield | -7.3% |
| Sector P/E (Healthcare) | 21.7 |
BNTC overview · BNTC earnings · BNTC KPIs · BNTC investor relations · BNTC ownership · BNTC peers · BNTC filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.